BioVaxys Expands Cancer Vaccine Platform
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer...
Source: prnewswire.com
📰 David Berd News
Page 2 - David Berd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Berd. Real-time updates on events, politics, business and more.
BioVaxys Technology Corp.: BioVaxys Expands Cancer Vaccine Platform
BVX-0922 to Target Colorectal Cancer Under Investigator-Sponsored IND VANCOUVER, BC, March 30, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys"
Source: finanznachrichten.de
The Power Play by The Market Herald Releases Interviews With Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp.
VANCOUVER, BC / ACCESSWIRE / March 30, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton
Source: finanznachrichten.de
Ovarian Cancer Cure from a Canadian Biotech Biovaxys? CEO James Passin Makes Bold Promise for H2 2022
James Passin, CEO of Biovaxys, makes some bold promises about his Canadian company's promising therapy for ovarian cancer.
Source: twst.com
Race to Develop Universal 'Variant-Proof' Covid Vaccine Involves Several Players
/PRNewswire/ -- USA News Group - Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight back with other than more...
Source: prnewswire.com
USA News Group: Race to Develop Universal 'Variant-Proof' Covid Vaccine Involves Several Players
FN Media Group Presents USA News Group News Commentary VANCOUVER, BC, March 24, 2022 /PRNewswire/ -- USA News Group - Whenever a new COVID-19 variant emergences, health authorities have
Source: finanznachrichten.de
BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University
VANCOUVER, BC, March 17, 2022 /CNW/ -- BioVaxys Technology Corp. , announced today that it has entered into an agreement with Millipore-Sigma a global Contract Development and Manufacturing... | March 17, 2022
Source: marketscreener.com
BioVaxys Technology Corp. announces bioproduction of BVX-1021 for its pan-sarbecovirus vaccine program with Ohio State University
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) revealed that it has struck an agreement with Millipore-Sigma to manufacture a supply of GLP-grade...
United States Ohio State University British Columbia David Berd Kenneth Kovan Biovaxys Technology Corp
Source: proactiveinvestors.com
Scientists are in pursuit of a coronavirus 'super shot' vaccine
In last 20 years, three different coronaviruses have emerged that are fatal to humans. The goal is to create a shot that will protect us from the next ones.
Source: montrealgazette.com
NA Proactive news snapshot: Nova Royalty Corp, Lucky Minerals Inc, PyroGenesis Canada Inc, GreenBank Capital Inc, Pathfinder Ventures Inc, Thunderbird Entertainment Group Inc, Numinus Wellness Inc, ESE Entertainment Inc, Heritage Cannabis Holding Corp, Al
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
Source: proactiveinvestors.com